Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

KCNQ2 Inhibitors

KCNQ2 inhibitors comprise a diverse group of compounds meticulously designed to modulate the activity of KCNQ2, a voltage-gated potassium channel subunit that plays a pivotal role in regulating neuronal electrical activity. These inhibitors are meticulously developed through a combination of structural insights and mechanistic studies, utilizing advanced techniques such as computational modeling, high-throughput screening, and chemical synthesis. The primary objective is to craft compounds that can selectively interact with KCNQ2, with the potential to perturb its channel activity and consequently influence the delicate balance of neuronal excitability. By targeting KCNQ2, these inhibitors provide valuable tools for unraveling the intricate mechanisms that underlie neuronal function and electrical signaling. The exploration of KCNQ2 inhibitors contributes to a deeper understanding of the complex interplay between ion channels and neuronal activity, shedding light on the fundamental processes that govern the dynamic behavior of neurons.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Vernakalant Hydrochloride

748810-28-8sc-475697
1 mg
$340.00
(0)

Although primarily investigated for its antiarrhythmic effects, vernakalant has also shown inhibitory effects on KCNQ2 channels, potentially impacting neuronal excitability.